Encompass Health Corporation Financials

Market Capitalization $10.71 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	19.99
Forward PE	18.32
Price to Sales TTM	$1.84
Price to Book MRQ	$4.50
Enterprise to Revenue	2.43
Enterprise to EBITDA	10.67

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-09-30
Profit Margin	9.34%
Operating Margin	16.49%
Return on Assets TTM	9.40%
Return on Equity TTM	24.41%

Income Statement

Revenue TTM	$5,795,599,872
Revenue per Share TTM	$57.75
Quarterly Revenue Growth	9.40%
Gross Profit TTM	$2,471,800,064
EBITDA	$1,342,400,000
Net Income to Common TTM	$540,499,968
Diluted EPS TTM	$5.31
Quarterly Earnings Growth YoY	16.90%

Balance Sheet

Total Cash MRQ	$48,700,000
Total Cash per Share MRQ	$0.48
Total Debt MRQ	$
Total Debt to Equity MRQ	83.53
Current Ratio MRQ	1.14
Book Value per Share MRQ	$23.57

Cash Flow

Operating Cash Flow TTM	$1,108,400,000
Levered Free Cash Flow TTM	$245,700,000

EHC Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	100,723,828
Float Shares	99,122,836
Avg 10 Volume	957,140
Avg 30 Volume	None
Shares Short	2,907,146
Short Ratio	3.45
Short % of Shares	3.26%
% Held by Insiders	1.41%
% Held by Institutions	97.78%

Stock Price Summary

Beta	0.58
Fifty Two Week Low	$90.26
Fifty Two Week High	$127.99
Fifty Two Week Change	14.25%
Day 50 MA	$114.13
Day 200 MA	$115.54

Dividends and Splits

Forward Annual Dividend Rate	$0.76
Forward Annual Dividend Yield	0.71%
Trailing Annual Dividend Rate	$0.70
Trailing Annual Dividend Yield	0.66%
Payout Ratio	13.18%
Dividend Date	2026-01-15
Ex Dividend Date	2026-01-02
Last Split Factor
Last Split Date	2022-07-01